000 04180nam a22005175i 4500
001 978-1-60327-502-6
003 DE-He213
005 20140220083734.0
007 cr nn 008mamaa
008 110803s2011 xxu| s |||| 0|eng d
020 _a9781603275026
_9978-1-60327-502-6
024 7 _a10.1007/978-1-60327-502-6
_2doi
050 4 _aRA427.9
072 7 _aMBPC
_2bicssc
072 7 _aMED029000
_2bisacsh
082 0 4 _a610
_223
100 1 _aSorrentino, Matthew J.
_eeditor.
245 1 0 _aHyperlipidemia in Primary Care
_h[electronic resource] :
_bA Practical Guide to Risk Reduction /
_cedited by Matthew J. Sorrentino.
250 _a1.
264 1 _aTotowa, NJ :
_bHumana Press,
_c2011.
300 _aXI, 300p. 13 illus., 5 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aCurrent Clinical Practice
505 0 _a1. Cardiovascular Risk Assessment -- 2. The Metabolic Syndrome -- 3. The Role of Imaging in Cardiovascular Risk Assessment -- 4. Inherited Lipoprotein Disorders -- 5. Advanced Lipid Testing -- 6. Therapeutic Lifestyle Change for the Prevention and Treatment of Hyperlipidemia and Coronary Artery Disease -- 7. Drug Therapy for Dyslipidemia -- 8. Hypertriglyceridemia -- 9. Isolated Low HDL -- 10. Lipoprotein(a) -- 11. HIV with Dyslipidemia -- 12. Treatment of Dyslipidemia in Patients with Renal Insufficiency and End-Stage Renal Disease.
520 _aCardiovascular disease is the number one cause of death for men and women in this country, surpassing deaths due to all cancers combined. Better awareness of heart disease risk factors and improved treatment modalities has produced great progress in reducing deaths due to myocardial infarction and stroke over the past few decades.  Still, more progress is needed, as about half of all first coronary events occur in individuals who have no cardiac symptoms and no previously diagnosed heart disease.  The primary care physician, therefore, has an important role in identifying at risk individuals and beginning preventive modalities.   In Hyperlipidemia in Primary Care: A Practical Guide to Risk Reduction, a group of leading authorities in the field offers a comprehensive overview of the problem along with practical strategies for treating it.   This unique title reviews methods for assessing risk in patients, including an important and thorough discussion of the Framingham algorithm and its limitations and advantages in assessing CVD risk.    The book also reviews the evolving world of lipidology and how to apply many of the newer lipid tests to patients in daily practice, putting these tests into proper perspective and offering a rational approach to using them in practice.   Finally, treatment issues are covered.   As treatment has expanded to more risk groups, a number of different guidelines have been published with recommended lipid goals. This is an evolving area of research with rapidly changing guidelines that are expanding the pool of high risk patients.   An invaluable reference that offers a reasonable approach to risk assessment and treatment of individuals at increased cardiovascular risk, Hyperlipidemia in Primary Care: A Practical Guide to Risk Reduction provides the background needed to make scientifically based decisions that can ultimately help greatly reduce the number of patients impacted by cardiovascular  disease.
650 0 _aMedicine.
650 0 _aFamily medicine.
650 0 _aObstetrics.
650 0 _aInternal medicine.
650 0 _aEmergency medicine.
650 1 4 _aMedicine & Public Health.
650 2 4 _aPrimary Care Medicine.
650 2 4 _aInternal Medicine.
650 2 4 _aGeneral Practice / Family Medicine.
650 2 4 _aObstetrics/Perinatology.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9781603275019
830 0 _aCurrent Clinical Practice
856 4 0 _uhttp://dx.doi.org/10.1007/978-1-60327-502-6
912 _aZDB-2-SME
999 _c106328
_d106328